PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
Chrysalis Health & Beauty Business Solutions Limited
 

Company Overview

Products & Services

Contact Info & Offices

Press Releases

Chrysalis Health & Beauty Business Solutions...

Press Release


Receive press releases from Chrysalis Health & Beauty Business Solutions Limited: By Email RSS Feeds:

EU Novel Foods Approved for Vitamin K2 Ingredient


Chrysalis Health & Beauty have announced the availability of Kappa K2Vital Vitamin K2 MK7 raw material for the UK and export markets following the successful EU Novel foods approval for this essential nutrient.

Nottingham, United Kingdom, March 30, 2012 --(PR.com)-- Chrysalis Health & Beauty announced today that they will start the sales and distribution of the recently EU novel food approved vitamin K2 as menaquinone-7 under the trade name K2VITAL™ from Norway based Kappa Biosciences.

The Novel Food application was submitted to the German Food Safety Agency by Kappa Bioscience and based on a positive German assessment, all the EU member states have acknowledged the novel food recommendation.

The K2VITAL™ product range will be sold into all European markets for food supplements, fortified foods and food products for specific nutritional purposes.

"This is a major achievement for all users of vitamin K2," said CEO Egil Greve of Kappa Bioscience. "Our products represent a technological break-through in the vitamin sector and provide the market with vitamin K2 of the highest possible purity and functionality - for use in tablets, capsules and fortification of food products. This now allows food and supplement manufactures to take vitamin K2 from a previous niche application into mainstream application due to a better cost-in-use proposition," he added.

Chrysalis Health & Beauty will be UK distributors for the new raw material range.

About Vitamin K2:
Vitamin K is a group of fat soluble vitamins known to be critical in blood coagulation. Vitamin K is divided into K1 (clotting activity) and vitamin K2, which also has extra hepatic activities. Vitamin K2 as menaquinon-7 (MK-7) has the highest bioavailability and has proven effects on bone health (EFSA 13.1 Claim) and cardiovascular health. Vitamin K2 acts as co-factor for proteins involved in calcium metabolism.

About K2VITAL
K2VITAL™ is Kappa Bioscience’s commercial product range containing pure, all-trans menaquinone-7 (MK-7). It is available in powder, granular and liquid form, each in various concentrations. K2VITAL™ is the most bio-available and cost effective form of vitamin K2 available for food and supplementation. This key nutrient offers significant health benefits for humans.

About Kappa Bioscience:
Kappa Bioscience is the innovative leader and first mover within high purity, all-trans vitamin K2 as menaquinone-7 (MK-7). Kappa Bioscience is a Norwegian based entity with substantial resources and knowledge about vitamins and vitamin K2 in particular. Kappa Bioscience is currently the only vendor with vitamin K2 as pure MK-7 in various formulations, following a traditional vitamin production process with proprietary and innovative new steps. For further information, visit http://www.kappabio.com
Contact Information
Chrysalis Health & Beauty Business Solutions Limited
Mark Broughton
+44 115 9771054
Contact
www.chrysalisweb.com

Click here to view the company profile of Chrysalis Health & Beauty Business Solutions Limited
Click here to view the list of recent Press Releases from Chrysalis Health & Beauty Business Solutions Limited
Promote Your Business